Alan00 Posted April 25, 2019 Share Posted April 25, 2019 Just to mention if people are interested, Crescita reported very positive Q4 & 2018 results recently: http://crescitatherapeutics.mediaroom.com/2019-03-21-Crescita-Therapeutics-Reports-Fourth-Quarter-and-Fiscal-2018-Results-Record-Annual-Revenue-of-16-6M-and-Adjusted-EBITDA-of-1-5M-Strong-Royalties-and-Sales-Milestones Then also today announced the re-acquisition of the RoW rights for Pliaglis and an out-licensing deal for 4 European countries, which I think sounds very positive: http://crescitatherapeutics.mediaroom.com/2019-04-25-Crescita-Therapeutics-Signs-Pliaglis-R-Out-Licensing-Agreement-with-Cantabria-Labs-for-EUR2-5M-Upfront-After-Reacquiring-Rest-of-World-Rights Link to comment Share on other sites More sharing options...
snowball82 Posted July 26, 2019 Author Share Posted July 26, 2019 https://www.crescitatherapeutics.com/wp-content/uploads/2019/07/Investor-Presentation-July-2019a.pdf Link to comment Share on other sites More sharing options...
DeepValuePlay Posted July 26, 2019 Share Posted July 26, 2019 Why did you post this Snowball? Link to comment Share on other sites More sharing options...
snowball82 Posted July 26, 2019 Author Share Posted July 26, 2019 Why did you post this Snowball? Maybe useful for at least one investor here. Maybe I'm too optimistic these days. Link to comment Share on other sites More sharing options...
snowball82 Posted August 12, 2019 Author Share Posted August 12, 2019 Record revenue announced recently but the largest shareholder (GUD) sold some shares. Adjusted EBITDA of $5 Million. Record revenue of $9.4 million, an increase of $7 million or 305 % vs Q2-2018. Q2-2019 revenue included $5.5 million in up-front payments and guaranteed future minimum royalties, both related to the out-licensing agreement with Cantabria. http://crescitatherapeutics.mediaroom.com/2019-08-08-Crescita-Reports-Profitable-2019-Second-Quarter-Results Link to comment Share on other sites More sharing options...
snowball82 Posted November 5, 2019 Author Share Posted November 5, 2019 U.S. Food and Drug Administration Approves Enhanced Formulation of Pliaglis® https://www.prnewswire.com/news-releases/us-food-and-drug-administration-approves-enhanced-formulation-of-pliaglis-300952361.html Link to comment Share on other sites More sharing options...
snowball82 Posted November 12, 2020 Author Share Posted November 12, 2020 + 39 % today after those results https://www.prnewswire.com/news-releases/crescita-reports-third-quarter-2020-results-301171830.html Link to comment Share on other sites More sharing options...
valueinvestor Posted November 13, 2020 Share Posted November 13, 2020 Am I getting the math correct. They earned $4M in a quarter. Cash is $14M. Market Cap is $17M? Link to comment Share on other sites More sharing options...
deleuze68 Posted November 13, 2020 Share Posted November 13, 2020 Earnings are extremely lumpy. I've been in and out of CTX over the years but this has been a great buy on any pullbacks. Link to comment Share on other sites More sharing options...
valueinvestor Posted November 13, 2020 Share Posted November 13, 2020 Thank you! Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now